Why? https://rxnav.nlm.nih.gov/InteractionAPIs.html#
On Sat, Mar 26, 2016 at 1:01 PM, Richard Boyce <rd...@pitt.edu> wrote: > (FYI for folks on the public-semweb-lifesci list who are not participating > in the task force [1]) > > Hello, > > Below I have pasted the minutes from the last meeting of the content > sub-team for the DDI Minimum Information Model task force [1]. I apologize > that I was forgot to record the meeting but I have tried to write detailed > minutes. The full set of minutes for the task force are available [2]. > > 1. https://sites.google.com/site/ddikrandir/home/ddi_info_model_taskforce > 2. https://goo.gl/TKWfNN > > ------------ > Minutes for 2/24/2016 (Content subgroup) > > In Attendance : Dan Malone, Evan Draper, John Horn, Oktie Hassanzadeh, > Richard Boyce, Sam Habiel > > Meeting recording: None taken (Rich forgot to start the recording, Sorry!) > > Meeting: > > - > > Brief discussion of progress on the proposed task force activities: > > > > 1. > > Clarify definitions for the seven minimum information items > recommended by prior AHRQ drug interaction conference series > - > > A sub-team has been working on creating definitions. Initial ideas > have been developed and will be discussed over the next month: > https://goo.gl/N0MxPd > - > > Some questions were raised by the sub-team that were discussed > later during the meeting. > > > > 1. > > Propose additional attributes > - > > Depends on Activity 1 > > > > 1. > > Create deliverables using an interesting and non-trivial set of > potential drug-drug interactions: > - > > Depends on Activities 1 and 2 > 2. > > Create a foundation for further collaborative work by disseminating > results through an interest group note, a website, and an online discussion > forum > - > > Ratnesh Sahay has created a project that will be used for advancing > development of the interest group note: > <https://github.com/W3C-HCLS/w3c-ddi> > https://github.com/W3C-HCLS/w3c-ddi > 1. > > A very initial outline can be seen here: <http://goo.gl/ZMU1Wm> > http://goo.gl/ZMU1Wm > 2. > > All persons who have participated in the calls have been listed > as contributors for now (in alphabetical order by first name). > Please email > Rich Boyce with spelling corrections and the affiliation you would > like (or > if you would like your name removed) > - > > Scott Nelson submitted a panel proposal on 3/10 to AMIA to discuss > the topic of including seriousness as a minimum information item > > > > - > > Discussion of what DDI content to include in our deliverables. > - > > Sub-team members had made progress on suggesting interacting pairs > based on known issues with DDI evidence and knowledge > - > > See https://goo.gl/rYpmjt > - > > Rich created a survey to increase the participation: > <https://pitt.co1.qualtrics.com/jfe/form/SV_0GPfzm7UbGDYV5X> > https://pitt.co1.qualtrics.com/jfe/form/SV_0GPfzm7UbGDYV5X > - > > Survey closes EOB Wednesday 3/30 > - > > It was decided that only one or two PDDIs will be selected for each > category. The group agreed that, for each PDDI, a decision tree will be > created that provides 1) information that can help contextualize the > interaction depending on drug and patient factors, 2) management > recommendations depending on the contextualizing factors in (1), and 3) > evidence supporting or refuting each scientific claim made for (1) > - > > Such decision trees have already been created by John Horn and > Phil Hansten for several interactions as part of Dan Malone’s AHRQ > grant > (R21HS023826). > - > > These can be used for the project as long as we provide > citation to the authors and grant. > - > > These interactions might fit as representative for certain > information categories. The group agreed that, for those cases, > additional > interactions will be chosen to provide heterogeneity > - > > Discussion of stakeholders > - > > The question of who the stakeholders are for the min info model > came up from the Standard sub-team. The content sub-team agreed that the > stakeholders included primarily the following: > - > > Clinicians (doctors, nurses, pharmacists, and various > practitioners) who must use PDDI information to make clinical > decisions > - > > Persons who create systems that provide PDDI information to > clinicians in various settings (e.g., database vendors, drug > information > editorial boards) > - > > Organizations that provide publicly available lists of drug-drug > interactions (e.g., developers of RxNorm) > - > > Clarification of this in writing is planned > - > > Discussion of use cases: > - > > Members of the standard sub-team had suggested using Medication > Reconciliation as a target use case for showing the value of the info > model > (e.g., competency questions). Rich asked the content sub-team for > comment > - > > It was agreed that med rec is an important use case but one that > can probably be broken down into a number of smaller use cases > depending on > the phase of the medication therapy process in question (e.g., > ordering, > consulting, monitoring) > - > > Clarification of this in writing is planned and also a focused > discussion at our “all team” meeting in May. > - > > Action Items > - > > Rich will merge the final results of the survey on suggested > PDDIs ( > <https://pitt.co1.qualtrics.com/jfe/form/SV_0GPfzm7UbGDYV5X> > https://pitt.co1.qualtrics.com/jfe/form/SV_0GPfzm7UbGDYV5X) into > the google sheet ( <https://goo.gl/rYpmjt>https://goo.gl/rYpmjt) > - > > He will then go through and highlight the PDDIs for which > decision trees have been created as part of Dan Malone’s AHRQ grant > - The next meeting will finalize the list and future meetings > will finalize decision trees for the chosen interactions. In > parallel, the > standard sub-team will work on representing the chosen interactions, > seeking feedback as they go. > > > -- > Richard D Boyce, PhD > Assistant Professor of Biomedical Informatics > Faculty, Center for Pharmaceutical Policy and Prescribing > Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and > Training Program > University of pittsburghrd...@pitt.edu > Office: 412-648-9219 > Twitter: @bhaapgh > > -- Timothy W. Cook, President Data Insights, Inc.